Royalty Pharma RPRX
NASDAQ RPRX
$67.13 +0.61 (+0.91%)
As of: Nov 3, 2026 · 12:03 PM EST

Royalty Pharma (RPRX) Long-Term Debt Issuances (2020 - 2025)

Updated

Royalty Pharma (RPRX) reported Long-Term Debt Issuances of $1.95 billion for FY2025, up 32.8% from $1.47 billion in FY2024.

Analysis

Royalty Pharma (RPRX) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

Dating back to FY2020, Royalty Pharma's Long-Term Debt Issuances record includes 5 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual Long-Term Debt Issuances since FY2020.
  • According to Business Quant data, Long-Term Debt Issuances came in at $1.47 billion in FY2024 (+320.4%), $350 million in FY2023 and $1.27 billion in FY2021 (-89.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Orix 40.92 Bn 9.64 Bn 12.74 Bn -
2 Rocket Companies 39.10 Bn 24.78 Bn - -
3 Federal National Mortgage Association Fannie Mae 30.68 Bn 30.68 Bn - 94.20 Bn
4 Royalty Pharma 29.92 Bn 26.88 Bn - -
5 Affirm Holdings 24.11 Bn 17.80 Bn - 10.72 Bn
6 Synchrony Financial 24.06 Bn -43.57 Bn - 2.09 Bn
7 Royal Gold 19.92 Bn 19.10 Bn 390.45 Mn -
8 Federal Home Loan Mortgage 15.72 Bn -2.96 Bn - 91.76 Bn
9 Annaly Capital Management 13.97 Bn 4.93 Bn - 7.10 Bn
10 Ares Capital 13.74 Bn 11.49 Bn - 3.55 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.23 Bn
Dec 31, 2023 350.00 Mn
Sep 30, 2021 1.27 Bn
Sep 30, 2020 5.85 Bn
Mar 31, 2020 6.04 Bn
API Access

Royalty Pharma Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RPRX&period=max&api_key=YOUR_API_KEY